Back

Bidirectional associations between cannabis use, oddball performance, and P3 event-related potential

Garasky, C.; Spychala, K.; Dong, F.; Anokhin, A.; Bogdan, R.; Chan, G.; Hesselbrock, V.; Kamarajan, C.; Kinreich, S.; Kuo, S.; Kutzner, J.; Miller, A. P.; Pandey, A.; Pandey, G.; Plawecki, M.; Salvatore, J.; Schuckit, M.; Bucholz, K.; McCutcheon, V.; Porjesz, B.; Meyers, J.; Agrawal, A.

2026-06-15 epidemiology
10.64898/2026.06.09.26355188 medRxiv
Show abstract

Importance: Cannabis use remains prevalent in youth despite concerns regarding its potential impact on cognitive function. Unraveling whether the association between cannabis use and cognition is partially due to preexisting differences or primarily related to use is vital to understanding underlying mechanisms. Objective: To estimate the longitudinal association between cannabis initiation and cognitive trajectories, indexed by task performance and P3 event-related potential (ERP), and to estimate whether baseline cognition is associated with cannabis initiation. Design: Data were analyzed from the ongoing longitudinal Collaborative Study on the Genetics of Alcoholism (COGA) cohort, which was followed up approximately every 2-5 years from 2004 to 2025. Setting: 6 sites across the United States. Participants: Adolescent and young adult offspring of past COGA participants and control families who reported on their cannabis use and who had Visual Oddball (VOP) performance and P3 ERP data (N=4814; 52.4% female, 68.4% white) were grouped based on the timing of cognitive data collection relative to cannabis initiation into Pre-onset (n=2,449; [&ge;]1 assessment) and Post-onset (n=998; [&ge;]3 assessments) subsamples. Main Outcomes and Measures: VOP measures include performance accuracy (%), reaction times (ms), and P3 amplitude (V) and latency (ms) during target trials. Cannabis measures included lifetime use of cannabis (i.e., ever used) and age at first use. Results: High P3 amplitude, and prolonged P3 latency and reaction time were associated with a reduced hazard of cannabis initiation (All Hazards Ratio, [H.R.s]< 0.91, p's<.008). Following initiation, cannabis use was associated with steeper declines in P3 amplitude (b=-0.29, p=0.02) and stabilized reaction time (b=0.35; p=0.005). Steeper decline in P3 amplitude (i.e., slope) was associated with greater cannabis progression (e.g., Cannabis Use Disorder, Odds Ratio, [O.R.]=2.34, p<.001), whereas steeper decline in reaction time was associated with reduced progression (O.R.=.79, p=.002). Conclusion: Baseline P3 indices and reaction time were associated with cannabis initiation, while cannabis use was associated with subsequent changes in P3 amplitude and reaction time trajectories. These findings indicate that accelerated neurodevelopment may modify the likelihood of cannabis initiation which, in turn, may further contribute to neurocognitive changes that deepen cannabis involvement.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Drug and Alcohol Dependence
41 papers in training set
Top 0.1%
19.0%
2
Alcoholism: Clinical and Experimental Research
14 papers in training set
Top 0.1%
10.0%
3
Addiction Biology
51 papers in training set
Top 0.1%
8.1%
4
Addiction
30 papers in training set
Top 0.1%
6.4%
5
Psychological Medicine
88 papers in training set
Top 0.3%
6.4%
6
PLOS ONE
5266 papers in training set
Top 33%
4.1%
50% of probability mass above
7
Translational Psychiatry
260 papers in training set
Top 2%
3.6%
8
Alcohol
18 papers in training set
Top 0.1%
3.3%
9
American Journal of Psychiatry
24 papers in training set
Top 0.2%
2.8%
10
Progress in Neuro-Psychopharmacology and Biological Psychiatry
48 papers in training set
Top 0.3%
2.5%
11
Scientific Reports
3612 papers in training set
Top 46%
2.2%
12
JAMA Psychiatry
15 papers in training set
Top 0.2%
2.0%
13
Alcohol, Clinical and Experimental Research
14 papers in training set
Top 0.1%
1.8%
14
BMC Psychiatry
25 papers in training set
Top 0.5%
1.5%
15
Psychopharmacology
69 papers in training set
Top 0.6%
1.2%
16
BMC Medicine
176 papers in training set
Top 4%
1.1%
17
Schizophrenia Research
35 papers in training set
Top 0.3%
1.0%
18
BMC Public Health
158 papers in training set
Top 5%
0.9%
19
JAMA Network Open
130 papers in training set
Top 4%
0.9%
20
International Journal of Neuropsychopharmacology
14 papers in training set
Top 0.4%
0.9%
21
Biological Psychiatry Global Open Science
60 papers in training set
Top 1%
0.9%
22
The Journal of Infectious Diseases
202 papers in training set
Top 4%
0.9%
23
Developmental Cognitive Neuroscience
96 papers in training set
Top 1%
0.9%
24
Neuropsychopharmacology
153 papers in training set
Top 2%
0.9%
25
Molecular Psychiatry
282 papers in training set
Top 5%
0.9%
26
American Journal of Preventive Medicine
11 papers in training set
Top 0.3%
0.9%
27
Journal of Psychiatric Research
32 papers in training set
Top 0.9%
0.9%
28
PLOS Medicine
110 papers in training set
Top 3%
0.9%
29
Neuropsychologia
85 papers in training set
Top 1%
0.6%
30
Schizophrenia
21 papers in training set
Top 0.4%
0.6%